Press release
Metabolomics Market Size Will Expected to Reach USD 9.5 Billion, Expanding at a CAGR of 12.3% by 2034 | TMR Research
Metabolomics Market
Metabolomics Market (대사체학 시장) is projected to advance at a CAGR of 12.3% from 2024 to 2034 and reach more than US$ 9.5 Bn by the end of 2034
Download Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=903
Overview of Metabolomics Market
The global metabolomics market is experiencing rapid growth, driven by advancements in analytical technologies, increasing investment in biomedical research, and the rising importance of personalized medicine. The market includes various segments such as mass spectrometry, nuclear magnetic resonance (NMR) spectroscopy, chromatography, bioinformatics tools, and services. Key end-users are pharmaceutical and biotechnology companies, academic and research institutions, and clinical laboratories.
Global Market Key Players
Waters Corporation
Agilent Technologies, Inc.
Thermo Fisher Scientific Inc.
Danaher Corporation
Bruker Corporation
PerkinElmer
Merck KGaA
Metabolon, Inc.
Afekta Technologies Ltd.
Shimadzu Corporation
Recent Developments in Metabolomics Market
Recent advancements and trends in the metabolomics market include:
Technological Advancements: Development of high-throughput and high-resolution analytical technologies such as mass spectrometry and NMR spectroscopy.
Integration with Other Omics: Combining metabolomics with genomics, proteomics, and transcriptomics to provide a more comprehensive understanding of biological systems.
Data Analysis and Bioinformatics: Enhancement of bioinformatics tools and software for better data integration, interpretation, and visualization.
Clinical Applications: Increasing application of metabolomics in clinical diagnostics, biomarker discovery, and therapeutic monitoring.
Personalized Medicine: Growing emphasis on personalized medicine approaches, where metabolomics plays a key role in tailoring treatments based on individual metabolic profiles.
Drivers of Market Growth
Several factors contribute to the growth of the metabolomics market:
Advancements in Analytical Technologies: Continuous improvements in analytical instruments and techniques enhance the accuracy and speed of metabolomic analysis.
Growing Biomedical Research: Increasing investment in biomedical research, particularly in cancer, cardiovascular diseases, and metabolic disorders, drives demand for metabolomics.
Need for Personalized Medicine: Rising focus on personalized medicine and precision healthcare fuels the adoption of metabolomics for individualized treatment plans.
Government and Industry Funding: Supportive government policies and funding initiatives for research and development in life sciences bolster market growth.
Expansion of Clinical Applications: Broadening application of metabolomics in clinical settings for disease diagnosis, prognosis, and therapeutic monitoring.
Explore Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=903
Conclusion
The metabolomics market is poised for significant growth, driven by technological advancements, increasing biomedical research, and the rising importance of personalized medicine. Innovations in analytical instruments, bioinformatics tools, and integration with other omics technologies are enhancing the capabilities and applications of metabolomics.
Market Segmentation
Product and Service Type
Metabolomic Instruments
Separation Tools
High Performance Liquid Chromatography
Gas Chromatography
Ultra Performance Liquid Chromatography
Capillary Electrophoresis
Detection Tools
Mass Spectrometry
Nuclear Magnetic Resonance Spectroscopy
Surface-based Mass Analysis
Bioinformatics Tools and Services
Bioinformatics Services
Bioinformatics Tools and Databases
Application
Biomarker Discovery
Drug Discovery
Toxicology Testing
Nutrigenomics
Personalized Medicine
Others
Indication
Oncological Disorders
Cardiovascular Disorders
Neurological Disorders
Metabolic Disorders
Others
End-user
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
By Region
North America
Latin America
Europe
Asia Pacific
Middle East & Africa
Buy this Premium Research Report:
https://www.transparencymarketresearch.com/checkout.php?rep_id=903<ype=S
More Trending Report by Transparency Market Research:
Gyroscope Market (Marché des gyroscopes): https://www.globenewswire.com/en/news-release/2024/03/18/2847641/32656/en/Gyroscope-Market-to-be-Worth-USD-1-5-billion-by-2031-Growing-a-CAGR-5-2-Exclusive-Report-by-Transparency-Market-Research-Inc.html
Cryotherapy Market (凍結療法市場): https://www.globenewswire.com/news-release/2024/07/03/2908096/0/en/Cryotherapy-Market-to-be-Worth-USD-885-7-million-by-2034-Growing-a-CAGR-9-3-Exclusive-Report-by-Transparency-Market-Research-Inc.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Metabolomics Market Size Will Expected to Reach USD 9.5 Billion, Expanding at a CAGR of 12.3% by 2034 | TMR Research here
News-ID: 3572817 • Views: …
More Releases from Transparency Market Research
Neuromorphic Chip Market to Reach USD 2.3 Billion by 2034, Driven by Explosive A …
The global Neuromorphic Chip Market is entering a defining phase of exponential growth, propelled by a surge in artificial intelligence (AI) applications, edge computing expansion, and rapid advancements in next-generation semiconductor technologies. According to the latest industry analysis, the market-valued at US$ 56.2 Mn in 2023-is projected to expand at an extraordinary CAGR of 40.1% from 2024 to 2034, reaching an estimated US$ 2.3 Bn by 2034.
Examine key highlights and…
Neuroprotection Market Surges Toward USD 60.1 Bn by 2031 as Global Neurological …
The global Neuroprotection Market continues to gain unprecedented momentum as healthcare systems worldwide intensify their focus on combating neurological disorders. With a valuation of US$ 31.6 Bn in 2022, the market is on track to reach US$ 60.1 Bn by 2031, expanding at a robust 7.5% CAGR during the forecast period. The rise in dementia, stroke, Parkinson's, epilepsy, and multiple sclerosis-combined with aging demographics and a surge in sedentary lifestyles-has…
Neuroregeneration Therapy Market Set to Reach USD 64.8 Bn by 2034, Driven by Inn …
The global neuroregeneration therapy market continues to chart steady, sustained growth. The increasing incidence of neurological disorders-including Alzheimer's disease, Parkinson's disease, multiple sclerosis, Huntington's disease, stroke, diabetic neuropathy, and spinal cord injuries-is significantly influencing market expansion. In 2023, the market was worth US$ 37.0 Bn, demonstrating rising demand for treatments capable of repairing or regenerating damaged neural tissue.
Examine key highlights and takeaways from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86322
With breakthroughs…
Neuroscience Market Set to Reach USD 41.6 Bn by 2031 Driven by Technological Adv …
The global neuroscience market stood at US$ 30.1 Bn in 2022, reflecting the significant technological and clinical potential of neurological research. Projected to grow at a CAGR of 3.7% from 2023 to 2031, the industry is expected to reach US$ 41.6 Bn by 2031. Rising prevalence of neurodegenerative diseases, advancements in neuroimaging, integration of artificial intelligence, and the emergence of brain-computer interfaces are shaping the next decade of neuroscience innovation.
Examine…
More Releases for Metabolomic
Metabolomic Platform Market A Comprehensive Study by Leading Key Players: Agilen …
HTF Market Insights just released the Global Metabolomic Platform Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major companies Metabolomic Platform Market are:
Agilent Technologies, Thermo Fisher…
Metabolomics Biomarker Market Growth in Future Scope 2024-2031 | BG Medicine Inc …
New Research report, titled "Metabolomics Biomarker Market" Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the worldwide market. The Metabolomics Biomarker market has been growing significantly in recent years, driven by a number of key factors, such as increasing…
Metabolomics Services Market Overall Study Report 2024-2031 | Thermo Fisher Scie …
𝐑𝐞𝐩𝐨𝐫𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
Coherent Market Insights announces the release of a new report titled Metabolomics Services Market: By Size, Trends, Share, Growth, Segments, Industry Analysis and Forecast, 2031. The research report conducts an in-depth market study to provide a comprehensive analysis of the current state and future potential of the Metabolomics Services Market. It covers several aspects, including industry size, key players, growth drivers, key opportunities, and challenges. Besides, market segmentation, competitive…
Preeclampsia Diagnostics Market size, share, demand and Opportunities Analysis b …
Preeclampsia is a disorder that can occur during pregnancy or after childbirth. It is characterized by high blood pressure and protein in the urine. Preeclampsia can be mild or severe. In severe cases, it can lead to eclampsia, which is a potentially life-threatening condition. Preeclampsia is diagnosed by measuring blood pressure and testing for protein in the urine. Treatment typically involves taking medications to lower blood pressure and monitoring the…
Breast Cancer Screening Market research report features players tapping emerging …
Newark, New Castle, USA: According to the deep-dive market assessment study conducted by Growth Plus Reports, the global Breast Cancer Screening market was pegged at US$ 2.50 billion in 2021. The market is expected to witness a CAGR of 6.7% from 2022 to 2030. The research report investigates the BioTime Inc., Siemens Healthcare Diagnostics Inc., A&G Pharmaceutical Inc., POC Medical Systems Inc., Biocrates Life Sciences AG
The global Breast Cancer Screening…
Metabolomic Platform Market Research Outlook: 2022, Growth Estimation, New Techn …
The "Metabolomic Platform Market" Research Report is an intelligence report that has been meticulously compiled to research relevant and valuable information. The data studied is designed with both the best existing players and future competitors in mind. The key player's business strategy and new market industries are studied in detail. The report makes future forecasts based on an analysis of market segmentation, including product categories, end-user applications, and global Metabolomic…
